Compare CRCT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | ATAI |
|---|---|---|
| Founded | 1969 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2021 | 2021 |
| Metric | CRCT | ATAI |
|---|---|---|
| Price | $5.08 | $4.38 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $4.18 | ★ $14.00 |
| AVG Volume (30 Days) | 602.3K | ★ 4.3M |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | ★ 18.76% | N/A |
| EPS Growth | ★ 27.98 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $714,492,000.00 | $3,018,000.00 |
| Revenue This Year | N/A | $943.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.70 | ★ N/A |
| Revenue Growth | N/A | ★ 811.78 |
| 52 Week Low | $3.94 | $1.15 |
| 52 Week High | $7.33 | $6.75 |
| Indicator | CRCT | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 51.66 |
| Support Level | $4.65 | $3.71 |
| Resistance Level | $4.90 | $3.95 |
| Average True Range (ATR) | 0.14 | 0.23 |
| MACD | 0.07 | 0.08 |
| Stochastic Oscillator | 100.00 | 84.04 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.